News
On track for first patient dosing of SER-252 in Phase 1b clinical trial in advanced Parkinson's disease in Q4 2025 Strengthened balance sheet with recent financing Advancing innovative POZ Platform ...
In our letters page this week, a reader bemoans the lack of protection for natural habitats from building developments.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results